Moderna and MSD publicize promising study of cancer vaccine
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/14710938/dmhsu9/ALTERNATES/schema-16_9/22300601928326-4660x2624ma.jpg)
Moderna, made a household name for its mRNA Covid-19 vaccine, is developing a personalized mRNA cancer vaccine for melanoma patients, and has just taken a further step in clinical development alongside pharmaceutical firm MSD.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Genmab presents promising new data for cancer hope in US
For subscribers